The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Cheremukhina Yu.V.

N.A. Semashko Regional Clinical Hospital

Borovkova N.Yu.

Privolzhsky Research Medical University

Vasilkova A.S.

Privolzhsky Research Medical University

Vlasova T.V.

Privolzhsky Research Medical University

Akhmedzhanov N.M.

National Medical Research Centre for Therapy and Preventive Medicine

Non-alcoholic fatty liver disease: a view formation on the problem and its significance for the clinical practice

Authors:

Cheremukhina Yu.V., Borovkova N.Yu., Vasilkova A.S., Vlasova T.V., Akhmedzhanov N.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(7): 127‑132

DOI: 10.17116/profmed202528071127

Read: 538 times

Buy for 300₽
Contact the author
Table of contents

NON-ALCOHOLIC FATTY LIVER DISEASE: A VIEW FORMATION ON THE PROBLEM AND ITS SIGNIFICANCE FOR THE CLINICAL PRACTICE
NON-ALCOHOLIC FATTY LIVER DISEASE: A VIEW FORMATION ON THE PROBLEM AND ITS SIGNIFICANCE FOR THE CLINICAL PRACTICE

To cite this article:

Cheremukhina YuV, Borovkova NYu, Vasilkova AS, Vlasova TV, Akhmedzhanov NM. Non-alcoholic fatty liver disease: a view formation on the problem and its significance for the clinical practice. Russian Journal of Preventive Medicine. 2025;28(7):127‑132. (In Russ.)
https://doi.org/10.17116/profmed202528071127

 
 
 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Problems of regu­lar medi­cal check-up orga­nization of young males aged 15—17 years with cardiometabolic diseases. Russian Journal of Preventive Medi­cine. 2024;(12):81-87
Epidemiology of suicidal beha­vior in children and adolescents worldwide. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):16-26
Multiparametric ultrasound effe­ctiveness in dete­cting and moni­toring non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):25-33
Liver and bone in tandem: osteopenia as an inevitable companion to non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):40-50
Hepa­tocellular carcinoma asso­ciated with nona­lcoholic fatty liver disease. P.A. Herzen Journal of Onco­logy. 2024;(6):57-62
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
The resu­lts of a 5-year clinical and epidemiological study of the National Program “Chronic tonsillitis”. Russian Bulletin of Otorhinolaryngology. 2024;(6):28-39
Abstract:

The problem of non-alcoholic fatty liver disease (NAFLD) is of great interest to the medical community due to its high prevalence and its proven role in the development and progression of cardiometabolic disorders and cancer.

OBJECTIVE

To analyze data related to epidemiology, developing of views on etiology and modern approaches to diagnosing of non-alcoholic fatty liver disease.

MATERIALS AND METHODS

The PubMed, RSCI, and eLibrary databases were searched for Russian and foreign publications using the keywords non-alcoholic fatty liver disease, obesity, cardiovascular risks, and insulin resistance. The data presented in reviews, articles, meta-analyses, and clinical guidelines were analyzed. Publication selection criteria were relevant articles in peer-reviewed periodicals with epidemiological data and a modern view of the problem of NAFLD with detailed descriptive statistics. The search period included 2014 to 2024. In addition, the review uses sources published earlier than 2000 with relevant data on the study topic.

RESULTS

The problem analysis demonstrated a high prevalence of NAFLD (averaging about 33% in the general population). Studies of non-alcoholic liver injury have been ongoing for a long time. According to modern views, this condition has a complex pathogenesis involving the hepatobiliary system and other organs and systems. New non-invasive diagnostic methods (elastometry, magnetic resonance imaging of the liver) are promising since they can detect the disease early.

CONCLUSION

Non-alcoholic fatty liver disease is well understood. However, more evidence of its role in developing other diseases associated with metabolic dysfunction is being revealed. It is necessary to search for new methods of diagnosing and treating this condition to improve the prognosis and reduce cardiometabolic risk.

Keywords:

non-alcoholic fatty liver disease
metabolic syndrome
epidemiology
etiopathogenesis
diagnosis

Authors:

Cheremukhina Yu.V.

N.A. Semashko Regional Clinical Hospital

Borovkova N.Yu.

Privolzhsky Research Medical University

Vasilkova A.S.

Privolzhsky Research Medical University

Vlasova T.V.

Privolzhsky Research Medical University

Akhmedzhanov N.M.

National Medical Research Centre for Therapy and Preventive Medicine

Received:

31.01.2025

Accepted:

13.05.2025

Close metadata

References:

  1. Maev IV, Andreev DN, Kucheryavyj YuA. Rasprostranennost' nealkogol'noj zhirovoj bolezni pecheni v Rossii: metaanaliz. Consilium Medicum. 2023; 25(5):313-319. (In Russ.). https://doi.org/10.26442/20751753.2023.5.202155
  2. Ivashkin VT, Drapkina OM, Maev IV, et al. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2016;25(6):31-41. (In Russ.). https://www.gastro-j.ru/jour/article/view/1036/717
  3. Vinickaya EV, Sandler YuG, Bordin DS. The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver Disease. Effektivnaya farmakoterapiya. 2020;16(24):54-63. (In Russ.). https://doi.org/10.33978/2307-3586-2020-16-24-54-63
  4. Klinicheskie rekomendacii. Nealkogol`naya zhirovaya bolezn` pecheni u vzrosly`x. 2024. Accessed May 25, 2025. (In Russ.). https://rsls.ru/files/KRNGBP2024.pdf
  5. Best CH, Hartroft WS. Liver damage produced by feeding alcohol or sugar and its prevention by choline. British Medical Journal. 1949;2(4635):1002-1006. https://doi.org/10.1136/bmj.2.4635.1001
  6. Hanssen P. Enlargement of the liver in diabetes mellitus. JAMA. 1936;106: 914-916. 
  7. Thaler H. The fatty liver and its pathogenetic relation to liver cirrhosis. Virchows Archiv fur pathologische Anatomie und Physiologie und fur Klinische Medizin. 1962;335:180-210. 
  8. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings. 1980;55(7):434-438. 
  9. Mayo Clinic Gastroenterology and Hepatology Board Review. Editor-in-chief S.C. Hauser; associate editors A.S. Oxentenko, W. Sanchez. 5th edition. 2015.
  10. Maccalau AJ. New information for non-alcoholic fatty liver disease. Journal of Clinical Gastroenterology. 2002;34:255-262. 
  11. Nonalcoholic steatohepatitis clinical research network. Hepatology. 2003; 37(2):244.  https://doi.org/10.1002/hep.510370203
  12. Lavine JE, Schwimmer JB. Pediatric non-alcoholic steatohepatitis. Non-alcoholic steatohepatitis. Ed. by G. Farrell, J. George, P. Hall, A. McCollough. Oxford, England: Blackwell Publishing; 2004;229-240. 
  13. Krolevec TS, Livzan MA. Non-alcoholic fatty liver disease: digest 2021. Russian Journal of Evidence-Based Gastroenterology. 2021;10(2):27-35. (In Russ.). https://doi.org/10.17116/dokgastro20211002127
  14. Day CP, James OF. Steatohepatitis: a tale of two «hits»? Gastroenterology. 1998;114:842-845.  https://doi.org/10.1016/s0016-5085(98)70599-2
  15. Sharma M, Mitnala S, Vishnubhotla RK, et al. The Riddle of Nonalcoholic Fatty Liver Disease: Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. Journal of Clinical and Experimental Hepatology. 2015;5(2):147-158.  https://doi.org/10.1016/j.jceh.2015.02.002
  16. Maev IV, Andreev DN, Kucheryavyy YuA, et al. Metabolicheski assotsiirovannaia zhirovaia bolezn’ pecheni. M.: Prima Print; 2021. (In Russ.).
  17. Maev IV, Kucheryavy YuA, Andreev DN. Pechen‘ i biliarnyi trakt pri metabolicheskom syndrome. Posobie dlia vrachei. M., 2020. (In Russ.).
  18. Tsukanov VV, Osipenko MF, Beloborodova EV, et al. Practical aspects of clinical manifestations, pathogenesis and therapy of alcoholic liver disease and non-alcoholic fatty liver disease: Expert opinion. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2023;33(4):7-13. (In Russ.). https://doi.org/10.22416/1382-4376-2023-33-4-7-13
  19. Halilova DM, Sahautdinova GM. About the role of intestinal microbiota in the pathogenesis and treatment of non-alcoholic fatty liver disease. Lechashchij Vrach. 2024;5(27):48-56. (In Russ.). https://doi.org/10.51793/OS.2024.27.5.009
  20. Liu C, Liu T, Zhang Q, et al. New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk. JAMA Network Open. 2023;6(9):e233551. https://doi.org/10.1001/jamanetworkopen.2023.35511
  21. Maevskaya MV, Kotovskaya YuV, Ivashkin VT, et al. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv. 2022;94(2): 216-253. (In Russ.). https://doi.org/10.26442/00403660.2022.02.201363
  22. Nelidova AV, Livzan MA, Nikolaev NA, et al. Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy. Racional'naya farmakoterapiya v kardiologii. 2021;17(6): 880-888. (In Russ.). https://doi.org/10.20996/1819-6446-2021-12-14
  23. SHabanin SA, Pchelin IYu. Specific features of metabolic disorders in males and females with non-alcoholic fatty liver disease. Juvenis scientia. 2020; 6(6):18-32. (In Russ.). https://doi.org/10.32415/jscientia_2020_6_6_18-32
  24. Nosov AE, Zenina MT, Gorbushina OYu, et al. Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies. Terapevticheskij arhiv. 2021;93(8):883-889. (In Russ.). https://doi.org/10.26442/00403660.2021.08.200973
  25. Ivashkin VT, Maevskaya MV, Zharkova MS. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2022;32(4):104-140. (In Russ.). https://doi.org/10.22416/1382-4376-2022-32-4-104-140
  26. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-1090. https://doi.org/10.1002/hep.24452
  27. Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clinical and Molecular Hepatology. 2017;23(4):290-301.  https://doi.org/10.3350/cmh.2017.0042
  28. Allakhverdieva YaS, Vorob’ev SV, Mineev NI. Modern opportunities of magnetic-resonance technologies in diagnostics of the fatty liver. Medicinskij vestnik Severnogo Kavkaza. 2018;13(4):695-700. (In Russ.). https://doi.org/10.14300/mnnc.2018.13140
  29. Caussy C, Reeder SB, Sirlin CB, et al. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology. 2018;68(2):763-772.  https://doi.org/10.1002/hep.29797
  30. Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease- MRI accurately quantifies hepatic steatosis in NAFLD. Alimentary Pharmacology and Therapeutics. 2012;36:22-29.  https://doi.org/10.1111/j.1365-2036.2012.05121.x
  31. Trang A, Tan J, Sun M. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013; 267:422-431.  https://doi.org/10.1148/radiol.12120896
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.